29
290660.KQ Neofect Co.Ltd
- Market cap
- KRW 51.6B
- P/E
- -
- P/B
- 0.93x
- ROE
- -38.6%
- Dividend yield
- -
- Fundamental score
- 1.3/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 290660.KQ undervalued?
Graham numberThe Graham number of Neofect Co.Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Neofect Co.Ltd fundamental analysis
6 of 21 checks passedROE 0/2
Low return on equity (-38.6%), below 10%.
ROA 0/1
Return on assets (-22.1%) is below the industry median (6.2%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-1,194.6%) is below the industry median (0.5%).
Revenue Growth 0/2
Revenue shrank 15.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.3%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Cash Runway 1/2
Cash covers 1.7 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (0.9x) is above the industry median (0.7x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Neofect Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to pr…
Full company profileNeofect Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Neofect Co.Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.98B | 4.45B | 5.65B | 12.3B | 18.6B | 23.2B | 26.2B | 26.6B | 21.1B | 16.1B | 14.6B |
| Gross Profit | 976M | 2.88B | 4.18B | 3.23B | 2.53B | 6.25B | 7.49B | 8.14B | 9.75B | 7.53B | 6.91B |
| Operating Income | -3.54B | -4.22B | -5.24B | -14.1B | -14.7B | -7.63B | -7.75B | -7.14B | 1.80B | -2.90B | -8.04B |
| EBITDA | - | - | - | - | - | - | -4.40B | 446M | 3.14B | -5.35B | -14.4B |
| Net Income | -5.92B | -4.39B | -9.63B | -15.8B | -15.0B | -5.04B | -9.62B | -4.96B | -951M | -12.3B | -21.4B |
| EPS | -1,261 | -904 | -712 | -1,160 | -794 | -267 | -1,000 | -128 | -23 | -292 | -499 |
| Balance Sheet | |||||||||||
| Total Assets | 7.93B | 10.2B | 35.9B | 47.0B | 57.9B | 52.5B | 50.4B | 71.7B | 72.4B | 77.8B | 96.5B |
| Total Liabilities | 22.1B | 27.4B | 7.67B | 34.6B | 42.7B | 40.2B | 40.8B | 42.8B | 33.5B | 24.6B | 41.3B |
| Shareholders' Equity | -14.2B | -17.2B | 28.3B | 12.4B | 15.2B | 12.4B | 6.48B | 28.9B | 38.9B | 53.3B | 55.3B |
| Cash & Short-term Investments | 4.59B | 3.90B | 22.4B | 9.09B | 14.4B | 5.80B | 1.02B | 23.6B | 27.0B | 32.9B | 16.7B |
| Total Debt | 11.6B | 17.7B | 4.87B | 5.61B | 8.47B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -4.92B | -7.18B | -8.18B | -13.9B | -9.06B | -4.84B | -5.70B | -4.35B | -1.14B | -233M | -6.55B |
| Capital Expenditure | 809M | 530M | 4.64B | 8.28B | 589M | 1.55B | 393M | 530M | 323M | 2.20B | 3.03B |
| Free Cash Flow | - | - | - | - | -10.1B | -6.39B | -6.09B | -4.88B | -1.46B | -2.44B | -9.58B |
| Ratios | |||||||||||
| ROE | - | - | -34.1% | -127.7% | -98.5% | -40.8% | -148.4% | -17.2% | -2.4% | -23.1% | -38.6% |
| ROA | -74.6% | -43.0% | -26.8% | -33.7% | -25.9% | -9.6% | -19.1% | -6.9% | -1.3% | -15.8% | -22.1% |
| Net Profit Margin | -299.0% | -98.5% | -170.4% | -128.7% | -80.6% | -21.8% | -36.7% | -18.6% | -4.5% | -76.6% | -146.3% |
| Debt to Equity | - | - | 0.17x | 0.45x | 0.56x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Neofect Co.Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | KRW 49.0M | 5.09 | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:2 on Jun 25, 2026.
Who owns Neofect Co.Ltd
- Insiders 30.29%
- Institutions 0.00%
- Public & others 69.71%
- Shares outstanding 42.8M
- Free float 31.4M
Neofect Co.Ltd company profile
- Company name
- Neofect Co.Ltd
- Ticker
- 290660.KQ
- ISIN
- KR7290660000
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 57
- Fiscal year end
- December
- Address
- Gyeonggi Enterprise Growth Center, Seongnam-si, South Korea
- Phone
- 82 3 1889 8521
- Website
- neofect.com
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to promote improved functional reach and muscle control; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect Smart Table for dementia prevention and rehabilitation program; Neomano, a wearable robotic glove; Neofect Comcog, a cognitive rehabilitation program that helps patients with stroke, dementia, traumatic brain injury, brain tumor, and cerebral palsy; and Neofect TeleRehab, a teletherapy platform designed for remote rehabilitation, as well as a range of orthotic and assistive devices. The company was formerly known as Neofect Co., Ltd. and changed its name to Dynamic solution Co.,Ltd. in April 2026. The company was incorporated in 2010 and is headquartered in Seongnam-si, South Korea.
Neofect Co.Ltd management
2- Mr. Ho-young BanCEO & Executive Director · born 1977
- Mr. Yu-Jeong KimMD & Internal Director